Intesa Sanpaolo Start-Up Initiative - DE Biotech Roadshow

Frankfurt, DE - November 3, 2011

Biotechnologies & Healthcare

'The Chemistry Of Inversion' photo (c) 2010, [F]oxymoron - license: http://creativecommons.org/licenses/by/2.0/

Intesa Sanpaolo announces a new Frankfurt edition of its Start-Up Initiative, specializing on Biotechnologies & Healthcare.

The event is supported by the Italian Embassy in Berlin, Hessen Agentur, BA Frankfurt Rhein Main, ASSOBIOTEC and the Italian Chamber of Commerce for Germany.

It will take place in the morning of Thursday, November 3 at the Hotel Hessischer Hof, 40 Friedrich-Ebert-Anlage, Frankfurt am Main.

A selection of the most advanced tech start-ups will have a chance to pitch their projects to a panel of international investors and corporations.

If you wish to participate, please send an email to startup.frankfurt@intesasanpaolo.com


Selected Start-Ups
  • R&D of new drugs for childhood cancer (the first cause of death until 15 years of age)
  • Preclinical development of a novel proprietary peptide antibiotic. Other antibiotic and anticancer leads are in the pipeline.
  • We sell bioreactors, devices that allow to grow cells in a 3D environment and to generate tissues (for research, pharma and clinic applicati
  • We aim to address the big pharma’s increasing demand for truly innovative lead structures, by the full application of our “LeadEngine” appro
  • Cancer Biotech. Our mission is to develop new anti-tumor therapies based on anti-Trop-2 antibodies.